Relationship between immobilised artificial membrane chromatographic retention and the brain penetration of structurally diverse drugs.

Retention factors were determined for a set of 26 drugs, for which brain/blood concentration data are available, using immobilised artificial membrane (IAM) chromatography. The compound set represented acidic, basic and neutral drugs from various structural classes. The relationship between IAM retention and lipophilicity (n-octanol-water partition coefficient Koct), molecular size and acid/base character of the drugs and the relationship between brain distribution and IAM retention and the other parameters were analysed. IAM retention was increased with increases in lipophilicity and solute size, and decreased by the ionisation of acidic groups. Ionisation of basic groups had no significant effect. A three-parameter regression model with log Koct, molecular weight and an indicator parameter for the presence of carboxyl group explained 93% of the variation in log kIAM. The concentration ratio between brain and blood (log BB) was only weakly correlated with the IAM chromatographic retention or n-octanol-water partitioning. Three-parameter models taking ionisation and size into account, in addition to either log Koct or log kIAM, explained about 85% of the variation of log BB in the test set. Although IAM chromatography offers no advantage in these models, it seems to provide a better model than n-octanol-water partitioning for the membrane distribution of ionised compounds.

[1]  MARCEL H. BICKEL,et al.  Drug distribution as a function of binding competition. Experiments with the distribution dialysis technique , 1980, The Journal of pharmacy and pharmacology.

[2]  R Griffiths,et al.  Pharmacological studies with SK&F 93944 (temelastine), a novel histamine H1‐receptor antagonist with negligible ability to penetrate the central nervous system , 1986, British journal of pharmacology.

[3]  Bruce M. Cohen,et al.  Drug distribution between blood and brain as a determinant of antipsychotic drug effects , 1992, Biological Psychiatry.

[4]  Harpreet S. Chadha,et al.  Hydrogen bonding. 32. An analysis of water-octanol and water-alkane partitioning and the delta log P parameter of seiler. , 1994, Journal of pharmaceutical sciences.

[5]  R Griffiths,et al.  An approach to the design of brain-penetrating histaminergic agonists , 1993 .

[6]  Meindert Danhof,et al.  Critical factors of intracerebral microdialysis as a technique to determined the pharmacokinetics of drugs in rat brain , 1994, Brain Research.

[7]  Harpreet S. Chadha,et al.  Hydrogen bonding. 33. Factors that influence the distribution of solutes between blood and brain. , 1994, Journal of pharmaceutical sciences.

[8]  D. E. Patterson,et al.  Crossvalidation, Bootstrapping, and Partial Least Squares Compared with Multiple Regression in Conventional QSAR Studies , 1988 .

[9]  D. Abernethy,et al.  Physiological pharmacokinetics and pharmacodynamics of (+/-)-verapamil in female rats. , 1987, Biopharmaceutics & drug disposition.

[10]  R Griffiths,et al.  Development of a new physicochemical model for brain penetration and its application to the design of centrally acting H2 receptor histamine antagonists. , 1988, Journal of medicinal chemistry.

[11]  S. P. Gupta,et al.  QSAR studies on drugs acting at the central nervous system , 1989 .

[12]  S F Pong,et al.  Comparative studies on distribution, excretion, and metabolism of hydroxyzine-3H and its methiodide-14C in rats. , 1974, Journal of pharmaceutical sciences.

[13]  C. Hansch,et al.  The parabolic dependence of drug action upon lipophilic character as revealed by a study of hypnotics. , 1968, Journal of medicinal chemistry.

[14]  H. Wunderli-Allenspach,et al.  Partition coefficients in vitro: artificial membranes as a standardized distribution model , 1994 .

[15]  V A Levin,et al.  Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability. , 1980, Journal of medicinal chemistry.

[16]  C. Pidgeon,et al.  Preparation of mixed ligand immobilized artificial membranes for predicting drug binding to membranes. , 1994, Analytical chemistry.

[17]  G. Digenis,et al.  Metabolism and distribution of 1-[14C]alprazolam in rats. , 1992, Journal of pharmaceutical sciences.

[18]  G W Kunsman,et al.  Tissue distribution of ibuprofen in a fatal overdose. , 1993, The American journal of forensic medicine and pathology.

[19]  A. Leo,et al.  Hydrophobicity and central nervous system agents: on the principle of minimal hydrophobicity in drug design. , 1987, Journal of pharmaceutical sciences.

[20]  K. Dill,et al.  Solute partitioning into lipid bilayer membranes. , 1988, Biochemistry.

[21]  S. Okuyama,et al.  The mode of action of analgesic drugs in adjuvant arthritic rats as an experimental model of chronic inflammatory pain: possible central analgesic action of acidic nonsteroidal antiinflammatory drugs. , 1984, Japanese journal of pharmacology.

[22]  R. Spector,et al.  Transport of diphenhydramine in the central nervous system. , 1987, The Journal of pharmacology and experimental therapeutics.

[23]  C. Pidgeon,et al.  Membrane partition coefficients chromatographically measured using immobilized artificial membrane surfaces. , 1995, Analytical chemistry.

[24]  P F Morrison,et al.  Quantitative Microdialysis: Analysis of Transients and Application to Pharmacokinetics in Brain , 1991, Journal of neurochemistry.

[25]  S. Curry,et al.  Stability, human blood distribution and rat tissue localization of promazine and desmonomethylpromazine. , 1989, Biopharmaceutics & drug disposition.

[26]  T. Murakami,et al.  Application of microdialysis for study of caffeine distribution into brain and cerebrospinal fluid in rats. , 1992, Chemical & pharmaceutical bulletin.

[27]  T. Cooper,et al.  Imipramine and its metabolites: relationship to cerebral catecholamines in rats in vivo. , 1984, The Journal of pharmacology and experimental therapeutics.

[28]  C. Pidgeon,et al.  IAM chromatography: an in vitro screen for predicting drug membrane permeability. , 1995, Journal of medicinal chemistry.

[29]  G. Levy,et al.  Effect of heparin or salicylate infusion on serum protein binding and on concentrations of phenytoin in serum, brain and cerebrospinal fluid of rats. , 1981, The Journal of pharmacology and experimental therapeutics.

[30]  T. T. Ngo Molecular Interactions in Bioseparations , 1993, Springer US.

[31]  D J Greenblatt,et al.  Relationship of plasma and brain concentrations of caffeine and metabolites to benzodiazepine receptor binding and locomotor activity. , 1989, The Journal of pharmacology and experimental therapeutics.

[32]  Michael H. Abraham,et al.  The Factors that Influence Skin Penetration of Solutes * , 1995 .

[33]  R. Austin,et al.  Partitioning of ionizing molecules between aqueous buffers and phospholipid vesicles. , 1995, Journal of pharmaceutical sciences.

[34]  M. C. Guerra,et al.  Rm values and structure-activity relationship of benzodiazepines. , 1980, Journal of medicinal chemistry.

[35]  I. Pollard,et al.  Accumulation of theophylline, theobromine and paraxanthine in the fetal rat brain following a single oral dose of caffeine. , 1993, Brain research. Developmental brain research.

[36]  C. Pidgeon,et al.  Immobilized artificial membrane chromatography: supports composed of membrane lipids. , 1989, Analytical biochemistry.

[37]  C. Nemeroff,et al.  Centrally administered neurotensin inhibits pentobarbital metabolism in mice but not in rats , 1987, Neuroscience Letters.

[38]  Y. Dambisya,et al.  Dispositional study of opioids in mice pretreated with sympathomimetic agents , 1992, The Journal of pharmacy and pharmacology.

[39]  G. Levy,et al.  Isobolographic assessment of the convulsant interaction between theophylline and caffeine or pentylenetetrazol in rats. , 1990, Journal of pharmaceutical sciences.

[40]  Aalt Bast,et al.  Comprehensive medicinal chemistry , 1991 .

[41]  G. Schmalzing Metabolism and disposition of trifluoperazine in the rat. II. Kinetics after oral and intravenous administration in acutely and chronically treated animals. , 1977, Drug metabolism and disposition: the biological fate of chemicals.

[42]  A. Koshiro,et al.  Pharmacokinetic analysis of chlorpromazine in rat serum, cerebrospinal fluid and striatum. , 1995, Biological & pharmaceutical bulletin.

[43]  Wilfred D. Stein,et al.  Transport and Diffusion Across Cell Membranes , 1986 .

[44]  G. Levy,et al.  Kinetics of drug action in disease states. XVI. Pharmacodynamics of theophylline-induced seizures in rats. , 1986, The Journal of pharmacology and experimental therapeutics.

[45]  A. Buciński,et al.  Hydrophobicity parameter from high-performance liquid chromatography on an immobilized artificial membrane column and its relationship to bioactivity , 1995 .

[46]  M Danhof,et al.  Differences in intrinsic efficacy of benzodiazepines are reflected in their concentration‐EEG effect relationship , 1992, British journal of pharmacology.

[47]  Bruce M. Cohen,et al.  Blood to brain distribution of neuroleptics , 1987, Psychiatry Research.